Tada,

The biggest uncertainty in my opinion right now is whether the MACE event counts reported at the Sept 12th AGM and Nov 6th BIO-Europe (close to/around 200) and most recently in the Jan 7th, 2019 Biotech Showcase (over 200) are referring to adjudicated/confirmed 3-point MACE events? In other words, were there around 200 adjudicated 3-point MACE events as of Sept 12, 2018 and over 200 adjudicated 3-point MACE events as of January 7, 2019?

I posed this question to Sarah and she replied "....this has not been publicly disclosed. I reiterate the comment below that we will likely end up with a number over 250 due to additional narrow MACE events we will likely see during this time."

So could be Monday, it could be April. It all depends on the above unanswered clarification.

BDAZ

P.S. RVXoldtimer....nice post. However, I do think top-line Q2 as of right now. Q3 would be outside of their current guidance.....whatever that is worth.